tiprankstipranks
Trending News
More News >
Pharmaust Limited (AU:NUZ)
ASX:NUZ
Australian Market

Pharmaust Limited (NUZ) Financial Statements

Compare
26 Followers

Pharmaust Limited Financial Overview

Pharmaust Limited's market cap is currently AU$68.01M. The company's EPS TTM is AU$-0.019; its P/E ratio is -2.46; Pharmaust Limited is scheduled to report earnings on August 25, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21Jun 20Jun 19Jun 18
Income Statement
Total Revenue
Gross Profit$ 3.07M$ 1.92M$ 2.95M$ 3.34M$ 2.58M
Operating Income$ -2.75M$ -2.79M$ -2.17M$ -2.20M$ -2.92M
EBITDA$ -1.30M$ -958.36K$ -968.86K$ -1.33M$ -2.37M
Net Income$ -1.71M$ -1.34M$ -1.36M$ -1.55M$ -2.52M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 10.08M$ 10.95M$ 10.75M$ 8.60M$ 8.36M
Total Debt$ 1.39M$ 1.28M$ 1.47M$ 324.61K$ 425.64K
Net Debt$ -1.03M$ -1.74M$ -1.41M$ -1.77M$ -1.45M
Total Liabilities$ 2.23M$ 2.07M$ 2.22M$ 1.14M$ 1.22M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -1.38M$ -1.08M$ -1.30M$ -1.70M$ -2.42M
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow
Currency in USD

Pharmaust Limited Earnings and Revenue History

Pharmaust Limited Debt to Assets

Pharmaust Limited Cash Flow

Pharmaust Limited Forecast EPS vs Actual EPS